TEVAR has become the prefered option for the treatment of aortic diseases. Despite short-term clinical follow-up data are satisfactory, long-term effeacy is still not clear. Computational hemodynamics is conducive to demostrate the impact of TEVAR and aid clinicians to improve decision-making process.